直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Federal Circuit IP Blog

Presumption of Nexus Improper When Product Includes Features Not Claimed in the Patent

December 30, 2019

Authored and Edited by Alissa E. Green; Samhitha M. Medatia; Elizabeth D. Ferrill

In FOX Factory, Inc. v. SRAM, LLC, Appeal No. 2018-2024 (Fed. Cir. Dec. 18, 2019), the Federal Circuit vacated the PTAB’s decisions upholding a bicycle chainring patent owned by SRAM.  The Board incorrectly held that SRAM’s evidence of secondary considerations showed the patent is not obvious.

FOX Factory filed two IPRs seeking to cancel several claims of SRAM’s patent on obviousness grounds. The Board found the prior art references asserted by FOX Factory disclosed all the limitations of the patent’s independent claims and that a skilled artisan would have been motivated to combine the asserted prior art. SRAM provided evidence of secondary considerations including commercial success and industry praise, and the Board determined that SRAM was entitled to a presumption of nexus between the challenged claims and secondary considerations evidence pertaining to SRAM’s X-Sync chainrings. This led the Board to conclude that FOX had not shown that the challenged claims would have been obvious.

On appeal, the Federal Circuit vacated and remanded the Board’s determination, holding that the secondary considerations were not properly tied to the patent since the X-Sync included unclaimed features that may have contributed to its success. The Court said that the Board wrongly presumed a nexus, given that the patented invention related only to one of many features of the commercially successful bicycle chainring.  While noting that there need not be a perfect match between the patent and the product, the Court held that the patentee must demonstrate that the product is “essentially the claimed invention.”  Because here, SRAM described certain unclaimed features of its X-Sync chainring as “critical” in other patents, the Court concluded that a nexus could not be presumed.

Tags

Obviousness (35 USC § 103), Patent Trial and Appeal Board (PTAB)

Related Practices

Appeals, Issues, and Legal Strategy

Federal Circuit and Supreme Court Appeals

Contacts

Alissa E. Green
Associate
Washington, DC
+1 202 408 4305
Email
Elizabeth D. Ferrill
Partner
Washington, DC
+1 202 408 4445
Email

Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 


DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information. 

Related Insights

Conference

2026 EDTX Bench Bar Conference

October 28-30, 2026

Fort Worth

Conference

Georgia Life Sciences Summit 2026

August 25-26, 2026

Sandy Springs

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Charitable

TopGolf for the Troops 2026

June 11, 2026

Ashburn

Seminar

3rd AI, IP, & Legal Forum

June 6, 2026

Shangai

Articles

California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data

June 4, 2026

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP